Fundraising FoxTwo Bear Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Inimmuneinimmune.comin𝕏Series A · Jul 2020 · $22M✓ verified
Inimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases.
AI & Machine LearningBiotechDeep TechHealthtechWhitefish, US
Jay EvansinDavid BurkhartinHelene Bazin-LeeinKendal Ryterinalan joslynin
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.